|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
SLCTR |
|
Last refreshed on:
|
27 April 2013 |
|
Main ID: |
SLCTR/2009/010 |
|
Date of registration:
|
18/09/2009 |
|
Primary sponsor: |
|
|
Public title:
|
A comparison of low dose step-up and step-down FSH regimes in treatment of infertility due to anovulation
|
|
Scientific title:
|
A prospective randomized comparison between low dose step-up and step-down gonadotrophin regimes in controlled ovarian stimulation |
|
Date of first enrolment:
|
1/8/2009 |
|
Target sample size:
|
Twenty five treatment cycles in each study arm. |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.slctr.lk/trial_details.asp?reg_id={0A03AF52-C95B-4D57-A2F6-7936D3F01ACB} |
|
Study type:
|
Interventional |
|
Study design:
|
A propective randomized clinical trial with two study arms.
|
|
|
Countries of recruitment
|
|
Sri Lanka
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr. Thilina S Palihawadana
|
|
Address:
|
Faculty of Medicine, P O Box 6, Thalagolla Road, Ragama
|
|
Telephone:
|
0714089474 |
|
Email:
|
palihawadana_t@sltnet.lk |
|
Affiliation:
|
Lecturer, Department of Obstetrics and Gynaecology |
|
|
Name:
|
Dr. Thilina S Palihawadana
|
|
Address:
|
Faculty of Medicine, P O Box 6, Thalagolla Road, Ragama
|
|
Telephone:
|
0714089474 |
|
Email:
|
palihawadana_t@sltnet.lk |
|
Affiliation:
|
Lecturer, Dept of Obstetrics and Gynaecology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Subjects with WHO group II anovulation who are having either clomifene resistance or clomifene failure.
Exclusion criteria: Previous ovarian surgery or any endocrinopathy other than polycystic ovarian syndrome.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Anovulatory infertility
|
|
Intervention(s)
|
|
One study arm would recieve FSH in a low dose step-up regime while the other will recieve a low dose step-down regime.
|
|
Primary Outcome(s)
|
|
Ovulation rate, incidence of ovarian hyperstimulation syndorme, total FSH drug requirement.
|
|
Secondary Outcome(s)
|
|
Mono follicle development rate, endometrial thickness, Serum oestradiol levels with mature follicle, cycle cancellation rate
|
|
Secondary ID(s)
|
|
Nil known
|
|
Source(s) of Monetary Support
|
|
National Science Foundation
|
|